<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03113591</url>
  </required_header>
  <id_info>
    <org_study_id>MP-GJ15-01</org_study_id>
    <nct_id>NCT03113591</nct_id>
  </id_info>
  <brief_title>Evaluate the Effect of Osteo Introducer System in Total Hip Arthroplasty</brief_title>
  <official_title>Evaluate the Effect of Osteo Introducer System in Total Hip Arthroplasty: A Prospective, Multicenter, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Suzhou MicroPort OrthoRecon Co. LTD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Suzhou MicroPort OrthoRecon Co. LTD</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Osteo introducer system is the instruments used in minimal invasive THA. This study will
      compare the minimal invasive THA using the osteo introducer system and THA using common
      instruments, to show the non-inferiority of osteo introducer system in safety and efficacy of
      THA surgery.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 29, 2016</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation the restoration of hip function at 3 month</measure>
    <time_frame>3 month</time_frame>
    <description>Assessment the changes of Harris Hip Score at postoperative 3 month from preoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of X-ray</measure>
    <time_frame>1day, 6 week, 6 month</time_frame>
    <description>Assessment of position, confirm whether there is loosening, dislocation or fracture etc.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation the restoration of hip function at each time frame</measure>
    <time_frame>6 week, 3 month, 6 month</time_frame>
    <description>Assessment the Harris Hip Score at each time frame</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Barthel Index</measure>
    <time_frame>1day, 3day, 2 week, 6 week, 3 month, 6 month</time_frame>
    <description>Assessment the daily living activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Scale</measure>
    <time_frame>1day, 3day, 2 week, 6 week, 3 month, 6 month</time_frame>
    <description>Assessment the balance ability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>1day, 3day, 2 week</time_frame>
    <description>Assessment the degree of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The use of analgesics</measure>
    <time_frame>1day, 3day, 2 week, 6 week, 3 month, 6 month</time_frame>
    <description>Investigate the name and dosage of analgesics to indirectly assess the degree of pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>up to 6 month</time_frame>
    <description>Investigate all the adverse events happened during the study period</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laboratory Examinations</measure>
    <time_frame>3 day, 6 week</time_frame>
    <description>Collect the following laboratory results which reflect the traumatic stress:Glu, CRP, Alb, CK, TBA, UA, Ca, Mg, WBC, GRA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dislocation rate</measure>
    <time_frame>1day, 3day, 2 week, 6 week, 3 month, 6 month</time_frame>
    <description>Compare the dislocation rate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Joint Disease</condition>
  <arm_group>
    <arm_group_label>Osteo introducer group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>undergo minimal invasive total hip arthroplasty surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>undergo common total hip arthroplasty surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Minimum invasive total hip arthroplasty</intervention_name>
    <description>Minimum invasive total hip arthroplasty using the osteo introducer system</description>
    <arm_group_label>Osteo introducer group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Common total hip arthroplasty</intervention_name>
    <description>Common total hip arthroplasty using common instruments</description>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  With indications of total hip arthroplasty (e.g. non-inflammatory degenerative joint
             disease such as osteoarthritis, avascular necrosis, ankylosis; rheumatoid arthritis;
             correction of functional deformity, etc.)

          -  BMI&lt;30

          -  Subject is a candidate for primary total hip arthroplasty

          -  No obvious congenital abnormality in hip joint

          -  Subject has no mental illness, is willing to join the study voluntarily and sign the
             approved informed consent document; is willing and able to complete required study
             visits or assessments

        Exclusion Criteria:

          -  Subjects with inadequate neuromuscular status (e.g., prior paralysis, fusion and/or
             inadequate abductor strength), poor bone stock, poor skin coverage around the joint
             which would make the procedure unjustifiable

          -  Overt infection

          -  Distant foci of infections

          -  Allergy to metals

          -  Rapid disease progression as manifested by joint destruction or bone absorption
             apparent on X-ray

          -  Skeletally immature

          -  Neuropathic joints

          -  Hepatitis or HIV infection

          -  Neurological or musculoskeletal disease that may adversely affect gait or
             weight-bearing

          -  Pregnant or lactating women

          -  Subjects enrolled in another drug or device clinical investigation within 3 month

          -  Investigator has judged the subject is not suitable for the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Wenjun Dong</last_name>
    <phone>86-18930173529</phone>
    <email>26858973@qq.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Sixth People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200233</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenjun Dong</last_name>
      <phone>86-18930173529</phone>
      <email>26858973@qq.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2017</study_first_submitted>
  <study_first_submitted_qc>April 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 13, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total hip arthroplasty</keyword>
  <keyword>minimal invasive</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

